INREBIC

Swiss trademark · 765314 · Combined mark · In force

Register entry

Registration number
765314
Application number
09264/2021
Status
In force
Type
Combined mark
As registered
INREBIC ((fig.))
Filed
Jun 10, 2021
Registered
Jun 14, 2021
Published
Jun 14, 2021
Protected until
Jun 10, 2031
Colours claimed
Blau, grau.
Vienna classes
17.02.01, 17.02.02, 17.02.04, 26.03.23, 26.15.15
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate zur Verwendung bei der Behandlung von myeloproliferativen Erkrankungen, Myelofibrose, autoinflammatorischen Erkrankungen, Autoimmunerkrankungen, Blutkrankheiten, Krebs in den Bereichen Onkologie, Immunologie und Entzündung; pharmazeutische Präparate, nämlich Zytokin hemmende Medikamente; pharmazeutische Präparate, die das Immunsystem modulieren.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 14, 2021

    Registered

    Published in Swissreg on 14.06.2021

Parties

Holder

Impact Biomedicines, Inc.

IMPACT BIOMEDICINES, INC.

86 Morris Avenue, Summit, New Jersey 07901, US

Agent

Troller Hitz Troller, Rechtsanwälte

Schweizerhofquai 2 Postfach, 6002 Luzern

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.